Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Fanconi Anemia

Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin

Abstract

Nineteen patients with Fanconi anemia (FA) and bone marrow failure underwent bone marrow transplantation (BMT) from matched siblings. Median age at BMT was 8.7 years. Conditioning consisted of low-dose cyclophosphamide (CY 5 mg/kg × 4 days) and thoracoabdominal irradiation (TAI 400 cGy). Graft-versus-host disease (GVHD) prophylaxis was cyclosporin A (CsA) in 13 patients and CsA plus methotrexate in 6 patients. Antithymocyte globulin (ATG) was added in the pretransplant as well as the post-transplant period. All patients received high-dose acyclovir from day 2 pre-BMT to day 28 post BMT, and intravenous immunoglobulins (IVIG), 500 mg/kg weekly from day 7 pre-BMT to day 90 post BMT. No fungal prophylaxis was given. All patients engrafted, (median, 14 days for an absolute neutrophil count 0.5 × 109/l; median, 37 days for platelet count 20 × 109/l). Fourteen (74%) patients are alive with sustained engraftment and are transfusion independent. Three (16.6%) patients developed acute GVHD; none developed chronic GVHD. Five (26%) patients developed invasive fungal infections, and two (10%) developed fatal CMV disease. We believe the addition of ATG may have contributed to the increased incidence of severe life-threatening fungal and viral infections in our series. Bone Marrow Transplantation (2001) 27, 139–143.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Auerbach AD, Allen RG . Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the international Fanconi anemia registry Cancer Genet Cytogenet 1991 51: 1–12

    Article  Google Scholar 

  2. Alter BP, Young NS . The bone marrow failure syndromes In: Nathan DG, Oski FA (eds). Hematology of Infancy and Childhood, Vol 1 Saunders: Philadelphia, PA 1998 pp 259–272

  3. Alter B . Fanconi's anemia, current concepts Am J Pediatr Hematol Oncol 1992 14: 170–184

    Article  CAS  Google Scholar 

  4. Alter B . Fanconi's anemia and its variability Br J Haematol 1993 85: 9–14

    Article  CAS  Google Scholar 

  5. Liu JM, Buchwald M, Walsh CE, Young NS . Fanconi anemia and novel strategies for therapy Blood 1994 84: 3995–4007

    CAS  PubMed  Google Scholar 

  6. Butturini A, Gale RP, Verlander PC et al. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study Blood 1994 84: 1650–1655

    CAS  PubMed  Google Scholar 

  7. Gluckman E, Berger R, Dutreix J . Bone marrow transplantation for Fanconi anemia Semin Hematol 1984 21: 20–26

    CAS  PubMed  Google Scholar 

  8. Gluckman E . Allogeneic bone marrow transplantation in Fanconi anemia Bone Marrow Transplant 1996 18: (Suppl. 3) 33–35

    Google Scholar 

  9. Gluckman E, Devergie A, Schaison G et al. Bone marrow transplantation in Fanconi anaemia Br J Haematol 1980 45: 557–564

    Article  CAS  Google Scholar 

  10. Kohli-Kumar M, Morris C, DeLaat C et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors Blood 1994 84: 2050–2054

    CAS  PubMed  Google Scholar 

  11. Medeiros CR, Zanis-Neto J, Pasquini R . Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning Bone Marrow Transplant 1999 24: 849–852

    Article  CAS  Google Scholar 

  12. Zwaan C, Van Weel-Sipman M, Fibbe W et al. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience Bone Marrow Transplant 1998 21: 447–453

    Article  CAS  Google Scholar 

  13. Socié G, Devergie A, Girinski T et al. Transplantation for Fanconi's anaemia: long term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning Br J Haematol 1998 103: 249–255

    Article  Google Scholar 

  14. Zanis-Neto J, Ribeiro RC, Medeiros C et al. Bone marrow transplantation for patients with Fanconi anemia: a study of 24 cases from a single institution Bone Marrow Transplant 1995 15: 293–298

    CAS  PubMed  Google Scholar 

  15. Yabe M, Yabe H, Matsuda M et al. Bone marrow transplantation for Fanconi anemia, adjustment of the dose of cyclophosphamide for preconditioning Am J Pediatr Hematol Oncol 1993 15: 377–382

    CAS  PubMed  Google Scholar 

  16. Flowers M, Doney KC, Storb R et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience Bone Marrow Transplant 1992 9: 167–173

    CAS  PubMed  Google Scholar 

  17. Flowers M, Zanis J, Pasquini R et al. Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation Br J Haematol 1996 92: 699–706

    Article  CAS  Google Scholar 

  18. Gluckman E, Auerbach A . D, Horowitz M et al. Bone marrow transplantation for Fanconi anemia Blood 1995 86: 2856–2862

    CAS  PubMed  Google Scholar 

  19. Storb R, Deeg HJ, Pepe M et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial Br J Haematol 1989 72: 567–572

    Article  CAS  Google Scholar 

  20. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation (second of two parts) New Engl J Med 1975 292: 895–902

    Article  CAS  Google Scholar 

  21. Ferretti GA, Ash RC, Brown AT et al. Chlorhexidine for prophylaxis against oral infectious and associated complications in patients receiving bone marrow transplantation J Am Dent Assoc 1987 114: 461–467

    Article  CAS  Google Scholar 

  22. Berger R, Bernheim A, Gluckman E, Gisselbrecht C . In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients Br J Haematol 1980 45: 565–568

    Article  CAS  Google Scholar 

  23. Gluckman E, Devergie A, Dutreix J . Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation Br J Haematol 1983 54: 431–440

    Article  CAS  Google Scholar 

  24. Gluckman E . Radiosensitivity in Fanconi anemia: application to the conditioning for bone marrow transplantation Radiother Oncol 1990 18: (Suppl. 1) 88–93

    Article  Google Scholar 

  25. Hibberd P, Tolkoff-Rubin N, Conti D et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in antibody-positive renal transplant recipients Ann Intern Med 1995 123: 18–26

    Article  CAS  Google Scholar 

  26. Pascual M, Rubin R, Cosimi A . Minimizing the toxicity of antilymphocyte antibody therapy Transplant Proc 1996 28: 2113–2114

    CAS  PubMed  Google Scholar 

  27. Cano LE, Singer-Vermes LM, Costa TA et al. Depletion of CD8 (+) T cells in vivo impairs host defense of mice resistant and susceptible to pulmonary paracoccidioidomycosis Infect Immun 2000 68: 352–359

    Article  CAS  Google Scholar 

  28. Teramura M, Kobayashi S, Iwabe K et al. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism Br J Haematol 1997 96: 80–84

    Article  CAS  Google Scholar 

  29. Socié G, Henry-Amar M, Cosset JM et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia Blood 1991 74: 277–275

    Google Scholar 

  30. Pierga JY, Socie G, Gluckman E et al. Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation Radiother Oncol 1994 30: 55–58

    Article  CAS  Google Scholar 

  31. Deeg HJ, Socié G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients Blood 1996 87: 386–392

    CAS  Google Scholar 

Download references

Acknowledgements

We are extremely grateful to Dr Robert Stuart, (chairman of the Department of Oncology at the King Faisal Specialist Hospital) for his critical review of this manuscript. We are also grateful to Mrs Saada Mansour (clinical research coordinator) and to Mrs Cynthia Magpantay (research data analyst) for their excellent assistance in the data collection and analysis.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayas, M., Solh, H., Mustafa, M. et al. Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant 27, 139–143 (2001). https://doi.org/10.1038/sj.bmt.1702754

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702754

Keywords

Search

Quick links